RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,774,916 | +140.1% | 10,689,532 | +134.4% | 0.01% | +133.3% |
| Q2 2023 | $34,060,188 | -46.3% | 4,559,597 | -52.1% | 0.00% | 0.0% |
| Q1 2023 | $63,437,846 | +84.2% | 9,510,922 | +113.0% | 0.00% | 0.0% |
| Q4 2022 | $34,430,661 | -23.9% | 4,465,715 | +5.0% | 0.00% | -40.0% |
| Q3 2022 | $45,233,000 | +95.9% | 4,251,164 | +49.9% | 0.01% | +150.0% |
| Q2 2022 | $23,084,000 | +50.3% | 2,835,852 | +32.2% | 0.00% | +100.0% |
| Q1 2022 | $15,363,000 | -41.4% | 2,145,639 | +40.2% | 0.00% | -50.0% |
| Q4 2021 | $26,213,000 | -41.9% | 1,530,226 | -21.9% | 0.00% | -50.0% |
| Q3 2021 | $45,099,000 | -44.1% | 1,959,963 | -11.4% | 0.00% | -33.3% |
| Q2 2021 | $80,724,000 | – | 2,211,601 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $42,800,000 | 100.00% |
| Two Sigma Ventures, LP | 1,806,800 | $12,937,000 | 74.73% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28,290,000 | 31.54% |
| MV Management XI, L.L.C. | 1,971,908 | $14,119,000 | 9.80% |
| Data Collective IV GP, LLC | 5,941,120 | $42,538,000 | 9.03% |
| ArchPoint Investors | 1,267,430 | $9,075,000 | 3.13% |
| MIC Capital Management UK LLP | 1,388,889 | $9,944,000 | 1.94% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,806,000 | 1.09% |
| Samsara BioCapital, LLC | 539,236 | $3,861,000 | 0.97% |
| Pinz Capital Management, LP | 142,168 | $1,018,000 | 0.64% |